<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="radiology" lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher">JOHS</journal-id>
      <journal-id journal-id-type="nlm-ta">Journ of Health Scien</journal-id>
      <journal-title-group>
        <journal-title>Journal of HealthCare Sciences</journal-title>
        <abbrev-journal-title abbrev-type="pubmed">Journ of Health Scien</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2231-2196</issn>
      <issn pub-type="opub">0975-5241</issn>
      <publisher>
        <publisher-name>Radiance Research Academy</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">340</article-id>
      <article-id pub-id-type="doi">http://dx.doi.org/10.52533/JOHS.2024.41219</article-id>
      <article-id pub-id-type="doi-url"/>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Radiology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Radiological Evaluation of Liver Fibrosis: Elastography, MRI, and Non-Invasive Assessment in Hepatology&#13;
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ghamdi</surname>
            <given-names>Khalid Mohammed Al</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bawareth</surname>
            <given-names>Rozana Louai</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Almubarak</surname>
            <given-names>Adeeb Ali</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aljohani</surname>
            <given-names>Khaled Olaithah</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alrahma</surname>
            <given-names>Husain Ali</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alharbi</surname>
            <given-names>Badr Hameed</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abbas</surname>
            <given-names>Rana Rafat</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alqahtani</surname>
            <given-names>Faisal Mohammed</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="ppub">
        <day>24</day>
        <month>12</month>
        <year>2024</year>
      </pub-date>
      <volume>4</volume>
      <issue>12</issue>
      <fpage>792</fpage>
      <lpage>799</lpage>
      <permissions>
        <copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Fibrosis represents both a critical milestone and a clinically advanced point on the continuum in chronic liver disease, leading, respectively, to complications of such leading conditions as cirrhosis and hepatocellular carcinoma. The main purpose of this review was to report on efficacy, reliability, and clinical applicability, with an emphasis on the positioning of the above techniques in the practice of hepatology. Methods used to diagnose liver disease include biopsy and radiological evaluation. To date, biopsy has represented a reliable method of diagnosis but is invasive and carries certain risks, which may present some problems related to sampling variability. Such emergency-inducing conditions have now become promising alternatives to liver biopsy that include noninvasive radiological imaging methods like elastography and MRI in their improved safety, consistency, and accuracy for assessing liver fibrosis. Early diagnosis of fibrosis, therefore, supported by accurate diagnostics, will be fundamental for effective clinical management and improved outcomes. This article reviews new developments in the radiological assessment of liver fibrosis and focuses on the following: transient elastography, shear wave elastography, and MRI-based approaches such as magnetic resonance elastography, among other non-invasive approaches. The integration of AI, imaging using new biomarkers, personalizing diagnostic approaches, and improved non-invasive methods will help in better evaluation, more accurate diagnosis, and tailored hepatology treatment.&#13;
</p>
      </abstract>
      <kwd-group>
        <kwd>fibrosis</kwd>
        <kwd> invasive</kwd>
        <kwd> radiology</kwd>
        <kwd> MRI</kwd>
        <kwd> elastography</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>